Mergers & Acquisitions
Roche to buy U.S. biotech firm InterMune for $8.3 billion
Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.
Burger King in talks to buy Tim Hortons
Burger King (BKW.N) is in talks to combine with Canadian coffee and doughnut chain Tim Hortons Inc (THI.TO), a deal that would create a fast food powerhouse with a combined market capitalization of roughly $18 billion.
Ackman, other shareholders ask Allergan to call special meeting
Investors owning 31 percent of shares of Allergan Inc have asked the company to call a special shareholder meeting, activist shareholder William Ackman said on Friday, giving the hedge fund manager a victory in his fight to acquire the Botox maker.
Dynegy cuts exposure to wholesale power with deals worth $6.25 billion
Power company Dynegy Inc (DYN.N) said on Friday that it would buy coal and gas power plants for $6.25 billion to increase its presence in two less regulated eastern U.S. markets, sending its shares up as much as 22.5 percent.